Involvement of Ext1 and heparanase in migration of mouse FBJ osteosarcoma cells

Molecular and Cellular Biochemistry

Volumn 373, Issue 1-2, 2013, Pages 63-72

  Wang, Yinan ^a   Yang, Xiaoyan ^b   Yamagata, Sadako ^b   Yamagata, Tatsuya ^b   Sato, Toshinori ^a  

^a KEIO UNIVERSITY   (Japan)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cell motility; Ext1; FBJ osteosarcoma; Glycosaminoglycan; Heparan sulfate; Heparanase; Saccharide primer

Indexed keywords

EXOSTOSIN 1; GLYCOPROTEIN; HEPARAN SULFATE; HEPARANASE; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL MIGRATION; CELL MOTILITY; CELL TYPE; DOWN REGULATION; METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARBOHYDRATE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GLUCURONIDASE; HEPARITIN SULFATE; MICE; MOLECULAR SEQUENCE DATA; N-ACETYLGLUCOSAMINYLTRANSFERASES; OSTEOSARCOMA; RNA, SMALL INTERFERING;

EID: 84871790084     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1475-8     Document Type: Article

References (44)

1. Liu D, Shriver Z, Venkataraman G, El Shabrawi Y, Sasisekharan R (2002) Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc Natl Acad Sci USA 99:568-573
2. Sanderson RD (2001) Heparan sulfate proteoglycans in invasion and metastasis. Semin Cell Dev Biol 12:89-98
3. Hameetman L, David G, Yavas A, White SJ, Taminiau AH, Cleton-Jansen AM, Hogendoorn PC, Bovee JV (2007) Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas. J Pathol 211:399-409
4. McCormick C, Duncan G, Goutsos KT, Tufaro F (2000) The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA 97:668-673
5. Busse M, Feta A, Presto J, Wilen M, Gronning M, Kjellen L, Kusche-Gullberg M (2007) Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. J Biol Chem 282:32802-32810
6. Raskind WH, Conrad EU, Matsushita M, Wijsman EM, Wells DE, Chapman N, Sandell LJ, Wagner M, Houck J (1998) Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses. Hum Mutat 11:231-239
7. Wicklund CL, Pauli RM, Johnston D, Hecht JT (1995) Natural-history study of hereditary multiple exostoses. Am J Med Genet 55:43-46
8. Pikas DS, Li JP, Vlodavsky I, Lindahl U (1998) Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem 273:18770-18777
9. Peterson SB, Liu J (2010) Unraveling the specificity of heparanase utilizing synthetic substrates. J Biol Chem 285:14504-14513
10. Ilan N, Elkin M, Vlodavsky I (2006) Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38:2018-2039
11. Roy M, Marchetti D (2009) Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis. J Cell Biochem 106:200-209
12. Vlodavsky I, Friedmann Y (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108:341-347
13. Ramani VC, Yang Y, Ren Y, Nan L, Sanderson RD (2011) Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity. J Biol Chem 286:6490-6499
14. Purushothaman A, Uyama T, Kobayashi F, Yamada S, Sugahara K, Rapraeger AC, Sanderson RD (2010) Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. Blood 115:2449-2457
15. Li M, Song L, Qin X (2010) Glycan changes: cancer metastasis and anti-cancer vaccines. J Biosci 35:665-673
16. Hyuga S, Yamagata S, Tai T, Yamagata T (1997) Inhibition of highly metastatic FBJ-LL cell migration by ganglioside GD1a highly expressed in poorly metastatic FBJ-S1 cells. Biochem Biophys Res Commun 231:340-343
17. Mulloy B, Hart GW, Stanley P (2009) Structural analysis of glycans. In: Varki ACR, Esko JD et al (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor Laboratory Press, New York
18. Cummings RD, Etzler ME (2009) Antibodies and lectins in glycan analysis. In: Varki ACR, Esko JD et al (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor Laboratory Press, New York
19. Sato T, Hatanaka K, Hashimoto H, Yamagata T (2007) Syntheses of oligosaccharides using cell function. Trends Glycosci Glycotechnol 19:1-17
20. Ogasawara N, Katagiri YU, Kiyokawa N, Kaneko T, Sato B, Nakajima H, Miyagawa Y, Kushi Y, Ishida H, Kiso M, Okita H, Sato T, Fujimoto J (2011) Accelerated biosynthesis of neolacto-series glycosphingolipids in differentiated mouse embryonal carcinoma F9 cells detected by using dodecyl N-acetylglucosaminide as a saccharide primer. J Biochem 149:321-330
21. Miura Y, Yamagata T (1997) Glycosylation of lactosylceramide analogs in animal cells: amphipathic disaccharide primers for glycosphingolipid synthesis. Biochem Biophys Res Commun 241:698-703
22. Nakajima H, Miura Y, Yamagata T (1998) Glycosylation of amphipathic lactoside primers with consequent inhibition of endogenous glycosphingolipid synthesis. J Biochem 124:148-156
23. Zhu X, Hatanaka K, Yamagata T, Sato T (2009) Structural analysis of glycosphingolipid analogues obtained by the saccharide primer method using CE-ESI-MS. Electrophoresis 30:3519-3526
24. Kasuya MCZ, Wang LX, Lee YC, Mitsuki M, Nakajima H, Miura Y, Sato T, Hatanaka K, Yamagata S, Yamagata T (2000) Azido glycoside primer: a versatile building block for the biocombinatorial synthesis of glycosphingolipid analogues. Carbohydr Res 329:755-763
25. Sato T, Takashiba M, Hayashi R, Zhu X, Yamagata T (2008) Glycosylation of dodecyl 2-acetamido-2-deoxy-beta-d-glucopyranoside and dodecyl beta-d-galactopyranosyl-(1-4)-2-acetamido-2-deoxy-beta-d-glucopyranoside as saccharide primers in cells. Carbohydr Res 343:831-838
26. Prydz K, Dalen KT (2000) Synthesis and sorting of proteoglycans. J Cell Sci 113(Pt 2):193-205
27. Wang Y, Kumazawa T, Shiba K, Osumi K, Mizuno M, Sato T (2012) Glycosylation of Nα-lauryl-O-(β-d-xylopyranosyl)-l-serinamide as a Saccharide Primer in Cells. Carbohydr Res. doi: 10.1016/j.carres.2012.08.003
28. Yamagata S, Miwa M, Tanaka K, Yamagata T (1982) FBJ virus-induced osteosarcoma has type V collagen consisting of A, B and C-like chains in addition to type I collagen. Biochem Biophys Res Commun 105:1208-1214
29. Hyuga S, Kawasaki N, Hyuga M, Ohta M, Shibayama R, Kawanishi T, Yamagata S, Yamagata T, Hayakawa T (2001) Ganglioside GD1a inhibits HGF-induced motility and scattering of cancer cells through suppression of tyrosine phosphorylation of c-Met. Int J Cancer 94:328-334
30. Hyuga S, Yamagata S, Takatsu Y, Hyuga M, Nakanishi H, Furukawa K, Yamagata T (1999) Suppression by ganglioside GD1A of migration capability, adhesion to vitronectin and metastatic potential of highly metastatic FBJ-LL cells. Int J Cancer 83:685-691
31. Yamagata S, Tanaka R, Ito Y, Shimizu S (1989) Gelatinases of murine metastatic tumor cells. Biochem Biophys Res Commun 158:228-234
32. Zhang L, Wang Y, Wang L, Cao T, Hyuga S, Sato T, Wu Y, Yamagata S, Yamagata T (2011) Ganglioside GD1a negatively regulates hepatocyte growth factor expression through caveolin-1 at the transcriptional level in murine osteosarcoma cells. Biochim Biophys Acta 1810:759-768
33. Wang L, Takaku S, Wang P, Hu D, Hyuga S, Sato T, Yamagata S, Yamagata T (2006) Ganglioside GD1a regulation of caveolin-1 and Stim1 expression in mouse FBJ cells: augmented expression of caveolin-1 and Stim1 in cells with increased GD1a content. Glycoconj J 23:303-315
34. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108
35. Izumikawa T, Koike T, Shiozawa S, Sugahara K, Tamura J, Kitagawa H (2008) Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members. J Biol Chem 283:11396-11406
36. van den Born J, Salmivirta K, Henttinen T, Ostman N, Ishimaru T, Miyaura S, Yoshida K, Salmivirta M (2005) Novel heparan sulfate structures revealed by monoclonal antibodies. J Biol Chem 280:20516-20523
37. Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U (2002) Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2:521-528
38. Pawlowski KM, Majewska A, Szyszko K, Dolka I, Motyl T, Krol M (2011) Gene expression pattern in canine mammary osteosarcoma. Pol J Vet Sci 14:11-20
39. Liu D, Shriver Z, Qi Y, Venkataraman G, Sasisekharan R (2002) Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans. Semin Thromb Hemost 28:67-78
40. Ogishima T, Shiina H, Breault JE, Terashima M, Honda S, Enokida H, Urakami S, Tokizane T, Kawakami T, Ribeiro-Filho LA, Fujime M, Kane CJ, Carroll PR, Igawa M, Dahiya R (2005) Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene 24:6765-6772
41. Ogishima T, Shiina H, Breault JE, Tabatabai L, Bassett WW, Enokida H, Li LC, Kawakami T, Urakami S, Ribeiro-Filho LA, Terashima M, Fujime M, Igawa M, Dahiya R (2005) Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin Cancer Res 11:1028-1036
42. Rao G, Liu D, Xing M, Tauler J, Prinz RA, Xu X (2010) Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activation. Neoplasia 12:946-956
43. Baraz L, Haupt Y, Elkin M, Peretz T, Vlodavsky I (2006) Tumor suppressor p53 regulates heparanase gene expression. Oncogene 25:3939-3947
44. Abboud-Jarrous G, Atzmon R, Peretz T, Palermo C, Gadea BB, Joyce JA, Vlodavsky I (2008) Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment. J Biol Chem 283:18167-18176